Log in to save to my catalogue

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d499338758524d99942f9963faf75661

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

COVID-19, caused by SARS-CoV-2, lacks effective therapeutics. Additionally, no antiviral drugs or vaccines were developed against the closely related coronavirus, SARS-CoV-1 or MERS-CoV, despite previous zoonotic outbreaks. To identify starting points for such therapeutics, we performed a large-scale screen of electrophile and non-covalent fragment...

Alternative Titles

Full title

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d499338758524d99942f9963faf75661

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d499338758524d99942f9963faf75661

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-18709-w

How to access this item